HBIO NASDAQ
Harvard Bioscience, Inc.
1W: +4.8%
1M: +1.7%
3M: +31.3%
YTD: +27.9%
1Y: +86.2%
3Y: -80.2%
5Y: -89.1%
$8.34
+0.21 (+2.58%)
Weekly Expected Move ±2.8%
$8
$8
$8
$9
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships6
As Filer
counterparties named
2
As Counterparty
mentioned by others
3
Rel. Types
2022-04-28
Earliest Filing
2025-12-17
Latest Filing
customer: 4
partner: 1
target: 1
Counterparties (Filed by HBIO)
6 relationshipsCompanies named in HBIO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. | HBIO | customer | Borrower entering into a loan and security agreement | 2025-12-17 | View |
| HARVARD BIOSCIENCE, INC. | HBIO | customer | Borrower entering into Sixth Amendment to Credit Agreement | 2025-08-11 | View |
| WARNER INSTRUMENTS LLC | — | partner | Subsidiary Guarantor | 2025-08-11 | View |
| HARVARD BIOSCIENCE, INC. | HBIO | customer | Borrower under the Credit Agreement | 2025-03-12 | View |
| HARVARD BIOSCIENCE, INC. | HBIO | customer | Borrower party to the Third Amendment to Credit Agreement | 2024-04-03 | View |
| Biostage, Inc. | — | target | Former subsidiary involved in settlement and issuance of convertible preferred stock | 2022-04-28 | View |
Mentioned As Counterparty
2 mentionsOther companies that named HBIO in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| HRGN Biostage, Inc. | licensee | Licensor granting sublicense rights to the Harvard Apparatus mark | 2023-03-07 | View |
| HRGN Biostage, Inc. | partner | Former parent company of Biostage, Inc. that executed a settlement and entered into a Preferred Issuance Agreement to re | 2022-04-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-11 | Regulation FD; Exhibits | View | |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-06-02 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-05-12 | Regulation FD; Exhibits | View | |
| 2026-03-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-03-10 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-03-06 | Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Other Events; Financi | View | |
| 2026-02-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-29 | Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure; Financial Statements an | View | |
| 2026-01-20 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-17 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2025-12-05 | Other Events | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-03 | Notice of Delisting or Transfer | View | |
| 2025-09-09 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-08-13 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR